EVMN logo

Evommune, Inc.

EVMN
Healthcare|Biotechnology|US
$6.65
+0.28 (+4.40%)
Tangible Book / Share
$7.68
Cash / Share
$5.56
Financing Filings (last 12 months)
8
Shelf registrations / offering prospectuses — latest Nov 4, 2026 (424B3). Possible dilution.

Upcoming Data Readouts (1)

Oct 2027
Est. completion
P2Migraine
Study of EVO756 in Adults With Migraine
NCT07616128n=330

Recent Press Releases

Evommune Announces Webcast Discussing EVO570 and Its Expanding Immunology Portfolio Today at 8:30 a.m. ET
Nov 5, 2026 · Business Wire
Evommune Announces $30 Million Private Placement
Nov 4, 2026 · Business Wire
Evommune Enters into Agreement to In-License EVO570, a Potential Best-in-Class Oral VAV1 Molecular Glue Degrader, from Hinova Pharmaceuticals
Nov 4, 2026 · Business Wire
Evommune Presents Late-Breaking Phase 2a Proof-of-Concept Data Evaluating EVO301 in Atopic Dermatitis at European Academy of Dermatology and Venereology Congress
Oct 1, 2026 · Business Wire
Evommune Announces Late-Breaker Presentation of Phase 2a Data for EVO301 in Atopic Dermatitis at European Academy of Dermatology & Venereology 2026 Congress
Sep 23, 2026 · Business Wire
Evommune Announces Top-line Results from EVO756 Phase 2b Trial in Moderate-to-Severe Atopic Dermatitis
Sep 8, 2026 · Business Wire

SEC Filings (62)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 5, 20268-KMaterial eventDocumentIndex
Nov 4, 2026424B3Offering prospectusDocumentIndex
Nov 4, 20268-KMaterial eventDocumentIndex
Oct 1, 20268-KMaterial eventDocumentIndex
Sep 23, 20268-KMaterial eventDocumentIndex
Sep 15, 20268-KMaterial eventDocumentIndex
Sep 9, 2026424B3Offering prospectusDocumentIndex
Sep 9, 20268-KMaterial eventDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 14, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 6, 2026424B3Offering prospectusDocumentIndex
Aug 6, 202610-QQuarterly reportDocumentIndex
Aug 6, 20268-KMaterial eventDocumentIndex
Jul 30, 20268-KMaterial eventDocumentIndex
Jul 16, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jun 29, 2026424B3Offering prospectusDocumentIndex
Jun 29, 20268-KMaterial eventDocumentIndex
Jun 2, 2026424B3Offering prospectusDocumentIndex
Jun 2, 20268-KMaterial eventDocumentIndex
May 7, 2026424B3Offering prospectusDocumentIndex
May 7, 202610-QQuarterly reportDocumentIndex
May 7, 20268-KMaterial eventDocumentIndex
Apr 24, 2026EFFECTDocumentIndex
Apr 24, 2026424B3Offering prospectusDocumentIndex
Apr 21, 2026ARSAnnual report to holdersDocumentIndex
Apr 21, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 21, 2026DEF 14AProxy / shareholder voteDocumentIndex
Apr 17, 2026S-1IPO / offering registrationDocumentIndex
Apr 13, 20268-KMaterial eventDocumentIndex
Mar 5, 2026S-8Employee stock planDocumentIndex
Mar 5, 202610-KAnnual reportDocumentIndex
Mar 5, 20268-KMaterial eventDocumentIndex
Feb 19, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Feb 17, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Feb 13, 2026SC 13GPassive 5%+ stakeDocumentIndex
Feb 13, 20268-KMaterial eventDocumentIndex
Feb 10, 20268-KMaterial eventDocumentIndex
Dec 11, 202510-QQuarterly reportDocumentIndex
Dec 11, 20258-KMaterial eventDocumentIndex
Nov 17, 2025SC 13DActivist / 5%+ stakeDocumentIndex